Bone Disease in Severely Burned Children

• Status: Terminated
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Bone metabolism is adversely affected by severe burns in children for a period of time.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Medical Branch, Galveston
• Treatments: Tetracycline

Criteria

Inclusion Criteria:

• Children age 5-18 years old with at least 40% or more of their body burned.

Exclusion Criteria:

• Anyone with a burn covering less than 40% of the body or whose burn covers the front of both hipbones.

• Anyone younger than 5 years old, anyone with a history of cancer or other metabolic disease process, or anyone who is pregnant or has an allergy to Tetracycline will also be excluded.

• Anyone who has participated in an investigational drug trial within the past 60 days from date of admission will be excluded from this study.